Bowhead Specialty BOW
$34.25 −$0.02 (-0.06%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $34.16 -0.26%
Open$34.28
Prev close$34.27
Day range$34.24 – $34.41
Volume177.5K
Market cap$1.13B
P/E (TTM)19.4
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$171.76M+19.4% YoY
Net profit$12.94M-14.7% YoY
Diluted EPS$0.38-15.6% YoY
Free cash flow$191.31M+68.6% YoY
Operating cash flow$192.57M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Net margin9.3%
Return on equity13.6%
Return on assets2.4%
Liabilities / assets84.2%
Total debt$146.73M
Free cash flow / sales63.2%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $171.77M | $163.86M | $155.69M | $551.59M | $151.68M |
| Total Operating Revenue | $171.76M | $163.86M | $155.69M | $551.54M | $151.69M |
| Total Premiums Earned | $150.23M | $143.95M | $136.81M | $491.68M | $134.32M |
| -Net Premiums Written | $149.88M | $181.03M | $140.34M | $558.19M | $143.54M |
| -Increase Decrease in Net Unearned Premium Reserves | $357,000.00 | -$37.07M | -$3.53M | -$66.51M | -$9.23M |
| Fee Revenue and Other Income | $988,000.00 | $1.10M | $880,000.00 | $2.04M | $735,000.00 |
| -Other Income Expense | $988,000.00 | $1.10M | $880,000.00 | $2.04M | $735,000.00 |
| Net Investment Income | $20.56M | $18.82M | $18.03M | $57.83M | $16.55M |
| Net Realized Gain/Loss on Investments | -$15,000.00 | -$11,000.00 | -$21,000.00 | $43,000.00 | $73,000.00 |
| Net Foreign Exchange Gain/Loss | -$2,000.00 | $2,000.00 | -$8,000.00 | -$50,000.00 | $14,000.00 |
| Total Expenses | $155.85M | $143.20M | $135.12M | $484.24M | $133.89M |
| Loss Adjustment Expense | $101.05M | $96.95M | $91.48M | $328.02M | $91.09M |
| Policy Acquisition Expense | $16.99M | $15.82M | $13.89M | $46.51M | $13.17M |
| $3.20M | $3.27M | $3.16M | $2.01M | $1.24M | |
| -Interest Expense Non-Operating | $3.20M | $3.27M | $3.16M | $2.01M | $1.24M |
| Other Operating Expenses | $34.61M | $27.17M | $26.58M | $106.83M | $27.53M |
| Pretax Profit | $15.91M | $20.66M | $20.57M | $67.30M | $17.81M |
| Tax | $2.97M | $4.52M | $4.56M | $13.51M | $2.96M |
| Net Profit | $12.94M | $16.14M | $16.01M | $53.79M | $14.84M |
| Profit from Continuing Operations | $12.94M | $16.14M | $16.01M | $53.79M | $14.84M |
| Net Income to Parent Company | $12.94M | $16.14M | $16.01M | $53.79M | $14.84M |
| Net Income to Common Stockholders | $12.94M | $16.14M | $16.01M | $53.79M | $14.84M |
| Basic EPS | $0.39 | $0.49 | $0.49 | $1.64 | $0.45 |
| Diluted EPS | $0.38 | $0.48 | $0.48 | $1.59 | $0.44 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.86B | $2.68B | $2.48B | $2.37B | $2.37B |
| Cash and Cash Equivalents | $232.22M | $141.75M | $97.19M | $193.55M | $193.55M |
| Restricted Cash and Cash Equivalents | $40.39M | $23.07M | $44.34M | $40.23M | $40.23M |
| Total Investments | $1.62B | $1.59B | $1.53B | $1.37B | $1.37B |
| -Short Term Investments | $792.81M | $798.86M | $795.86M | $772.19M | $772.19M |
| -Equity Investments | $830.09M | $786.36M | $729.47M | $598.82M | $598.82M |
| Receivables | $602.80M | $592.88M | $519.32M | $487.16M | $487.16M |
| -Accounts Receivable | $598.71M | $588.58M | $517.90M | $484.09M | $484.09M |
| -Taxes Receivable | $4.09M | $4.31M | $1.43M | $3.07M | $3.07M |
| Accrued Investment Income | $13.60M | $13.69M | $11.33M | $10.96M | $10.96M |
| Net PPE | $12.43M | $11.95M | $11.31M | $10.64M | $10.64M |
| Prepaid Assets | $242.36M | $227.05M | $192.11M | $191.82M | $191.82M |
| Deferred Policy Acquisition Costs | $43.80M | $45.49M | $40.04M | $35.28M | $35.28M |
| Other Assets | $8.79M | $10.62M | $10.59M | $8.26M | $8.26M |
| Total Liabilities | $2.41B | $2.21B | $2.02B | $1.92B | $1.92B |
| Policy Holders Liabilities | $2.08B | $1.95B | $1.78B | $1.68B | $1.68B |
| Payables | $143.50M | $85.89M | $65.30M | $66.09M | $66.09M |
| -Accounts Payable | $143.18M | $85.58M | $59.09M | $65.78M | $65.78M |
| -Total Tax Payable | $311,000.00 | $314,000.00 | $6.21M | $314,000.00 | $314,000.00 |
| Current Accrued Expenses | $24.94M | $11.60M | $11.09M | $19.05M | $19.05M |
| Long Term Debt and Capital Lease Obligation | $146.73M | $146.57M | $146.52M | $146.45M | $146.45M |
| -Long Term Debt | $146.73M | $146.57M | $146.52M | $146.45M | $146.45M |
| Other Liabilities | $18.58M | $16.38M | $20.02M | $7.99M | $7.99M |
| Total Equity | $453.02M | $473.94M | $459.16M | $449.27M | $449.27M |
| Stockholders' Equity | $453.02M | $473.94M | $459.16M | $449.27M | $449.27M |
| Capital Stock | $329,000.00 | $329,000.00 | $328,000.00 | $328,000.00 | $328,000.00 |
| -Common Stock | $329,000.00 | $329,000.00 | $328,000.00 | $328,000.00 | $328,000.00 |
| Additional Paid-In Capital | $333.32M | $330.02M | $327.99M | $325.89M | $325.89M |
| Retained Earnings | $161.79M | $148.84M | $132.71M | $116.70M | $116.70M |
| Gains/Losses Not Affecting Retained Earnings | -$44.31M | -$6.83M | -$3.12M | $5.35M | $5.35M |
| Other Equity Interests | $1.90M | $1.58M | $1.26M | $1.01M | $1.01M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $192.57M | $93.88M | $65.46M | $331.59M | $60.15M |
| Net cash flow from continuing operations | $192.57M | $93.88M | $65.46M | $331.59M | $60.15M |
| Net Income from Continuing Operations | $12.94M | $16.14M | $16.01M | $53.79M | $14.84M |
| Gain/Loss from Continuing Operations | $15,000.00 | $11,000.00 | $21,000.00 | -$43,000.00 | -$73,000.00 |
| Deferred Tax | -$3.28M | -$846,000.00 | -$3.01M | -$6.53M | -$3.55M |
| Other Non-Cash Items | $325,000.00 | $321,000.00 | $317,000.00 | $2.05M | $1.14M |
| Change in Working Capital | $178.10M | $73.98M | $48.49M | $271.37M | $42.89M |
| -Change in Receivables | -$9.92M | -$73.56M | -$32.16M | -$167.83M | -$56.84M |
| -Change in Prepaid Assets | -$15.31M | -$34.94M | -$289,000.00 | -$39.25M | -$7.26M |
| -Change in Loss and Loss Adjustment Expense Reserves | $113.71M | $97.84M | $90.86M | $373.08M | $94.77M |
| -Change in Accrued Investment Income | $89,000.00 | -$2.36M | -$369,000.00 | -$3.44M | -$2.07M |
| -Change in Payables and Accrued Expense | $70.94M | $21.11M | -$8.75M | $13.70M | $2.74M |
| -Change in Unearned Premiums | $14.71M | $71.85M | $3.82M | $105.74M | $16.49M |
| -Change in Other Current Assets | $1.51M | -$356,000.00 | -$2.64M | -$2.30M | -$1.31M |
| -Change in Other Current Liabilities | $683,000.00 | -$164,000.00 | $2.78M | -$669,000.00 | -$1.81M |
| -Change in Other Working Capital | $1.69M | -$5.45M | -$4.76M | -$7.66M | -$1.81M |
| Net cash flow from investing | -$84.75M | -$69.24M | -$156.91M | -$464.39M | -$221.67M |
| Net Cash Flow from Continuing Investing Activities | -$84.75M | -$69.24M | -$156.91M | -$464.39M | -$221.67M |
| Net PPE Purchase and Sale | -$1.26M | -$1.36M | -$1.29M | -$5.57M | -$1.51M |
| Net Investment Purchase and Sale | -$83.48M | -$67.88M | -$155.62M | -$458.82M | -$220.16M |
| Financing Cash Flow | -$30,000.00 | -$1.35M | -$789,000.00 | $144.52M | $144.52M |
| Net Cash Flow from Continuing Financing Activities | -$30,000.00 | -$1.35M | -$789,000.00 | $144.52M | $144.52M |
| Net Other Financing Charges | -$30,000.00 | -$1.35M | -$789,000.00 | -$5.48M | – |
| Ending Cash Balance | $272.61M | $164.82M | $141.53M | $233.77M | $233.77M |
| Net Change in Cash | $107.79M | $23.29M | -$92.24M | $11.71M | -$17.01M |
| Beginning Cash Balance | $164.82M | $141.53M | $233.77M | $222.06M | $250.78M |
| Free Cash Flow | $191.31M | $92.53M | $64.17M | $326.02M | $58.64M |
| Net Common Stock Issuance | – | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Issuance Payments of Debt | – | – | – | $150.00M | – |
No comments yet — be the first to weigh in on BOW.
Sign in to join the discussion.